PATOLOGIE GASTROENTERICHE ONCOLOGICHE E CHIRURGICHEModule ONCOLOGIA MEDICA
Academic Year 2023/2024 - Teacher: GABRIELLA PELLEGRITIExpected Learning Outcomes
LEARNING AIMS
Students will have to describe the main mechanisms underlying cancer pathogenesis and will have to define the appropriate procedures required for the correct evaluation of cancer patients. Description of the current methodologies used to evaluate the nutritional status of neoplastic patients will also be required, in order to promptly recognize an initial malnutrition or a more serious cachexia. Students will also have to distinguish patients that should receive enteral nutrition from those that will require parenteral nutrition. Finally, nausea and vomiting induced by conventional chemotherapeutic drugs [CINV] will be discussed in great detail.
Course Structure
Required Prerequisites
Attendance of Lessons
Detailed Course Content
CLASS ORGANIZATION
Tumor Biology
· Oncogenes, Tumor Suppressor Genes
· Stochastic Cancerogenesis and basic Knowledge of Cancer Stem Cells
Diet and Cancer Prevention
· Eating Risk Factors for the Most Common Forms of Cancer
· Correct Diet and Cancer Prevention
Diet Management in Cancer Patients
· Cancer Patients and Malnutrition Risk: physiopathology, metabolic alterations and chemotherapy effects
· Nutritional Status Evaluation in Cancer Patients
Nutrition Principles During and After Cancer Treatments
· Nausea and Vomiting Induced by Conventional Chemotherapeutic Drugs [CINV]
· Enteral Nutrition
· Parenteral Nutrition
· Artificial Nutrition in Cancer Outpatients
Textbook Information
SUGGESTED TEXTBOOKS
1. Linee Guida AIOM-SINPE per la Nutrizione nel Paziente Oncologico - 2016 - AIOM-SINPE
2. Linee d'Indirizzo Percorsi Nutrizionali nel Paziente Oncologico - 2017 - Ministero dello Salute
3. Nutrition in Cancer Care - 2017 - National Cancer Institute
Learning Assessment
Learning Assessment Procedures
Examples of frequently asked questions and / or exercises
Indicate the drug, among those listed below, with the greatest emetizing power:
a] Adriamycin
b] Dacarbazine
c] Cisplatin
d] Paclitaxel